Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. Five out of 10 post-mortem brains of patients ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A new study from Stanford Medicine has found that stopping an overactive enzyme in the brain might help protect and even ...

A groundbreaking new study out of Northwestern Medicine may offer new hope for the more than one million Americans living ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...